CD44 and breast cancer: Histopathological analysis of mice tumor sections revealed a higher accumulation of necrotic debris correlating with the higher tumorigenic potential of the CD24−/CD44+‐breast CSCs as compared with CD24+‐breast cancer cells xenotransplanted groups (Figure 4C), which was quantified using Image J software (Figure 4C, right panel).